Want to join the conversation?
In 2Q16, $WBA's pharmacy sales were up 3.2%. 233MM prescriptions were filled on a 30-day basis including immunizations. This was an increase of 3.9%. On a comparable store basis, pharmacy sales increased by 3.7%. Consistent with expectations, $WBA saw a decline in pharmacy GM which were impacted by reimbursement pressure and changes in mix.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.